Skip to content
10-Q

Quarterly Report

GENPACT LIMITED G

0001398659-25-000059

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 6, 2025 174.87M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $1.19B
Long Term Debt Q1 2025 · Dec 31, 2024 $1.2B
Short Term Investments Q1 2025 · Mar 31, 2025 $0
Short Term Investments Q1 2025 · Dec 31, 2024 $23.36M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $561.62M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $648.25M
Current Liabilities Q1 2025 · Mar 31, 2025 $791.74M
Current Liabilities Q1 2025 · Dec 31, 2024 $963.74M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.44B
Total Liabilities Q1 2025 · Dec 31, 2024 $2.6B
Current Assets Q1 2025 · Mar 31, 2025 $1.94B
Current Assets Q1 2025 · Dec 31, 2024 $2.08B
Total Assets Q1 2025 · Mar 31, 2025 $4.89B
Total Assets Q1 2025 · Dec 31, 2024 $4.99B
Shares Diluted Q1 2025 · Mar 31, 2024 181.94M sh
Dividends Paid Q1 2025 · Mar 31, 2024 $27.49M
Capex Q1 2025 · Mar 31, 2024 $24.01M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$25.56M
Stockholders Equity Q1 2025 · Mar 31, 2024 $2.3B
Stockholders Equity Q1 2025 · Dec 31, 2023 $2.25B
Eps Diluted Q1 2025 · Mar 31, 2024 $0.64
Eps Basic Q1 2025 · Mar 31, 2024 $0.65
Sga Expense Q1 2025 · Mar 31, 2024 $235.03M
Net Income Q1 2025 · Mar 31, 2024 $116.95M
Operating Income Q1 2025 · Mar 31, 2024 $159.99M
Gross Profit Q1 2025 · Mar 31, 2024 $396.48M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $734.76M
Revenue Q1 2025 · Mar 31, 2024 $1.13B